Assessment of Atorvastatin Effectiveness on Serum PSA Level in Hypercholesterolemic Males
The previous large retrospective studies demonstrated that treatment with Statins reduces both the incidence of prostate cancer by 50% and serum Prostate Specific Antigen (PSA) level up to 40%. However the main problem in those studies was the absence of control groups of men with hypercholesterolem...
Main Authors: | Iradj Khosropanah, Siavash Falahatkar, Babak Farhat, Zhoobin Heidari Bateni, Ahmad Enshaei, Ali Akbar Allahkhah, Darya Khosropanah |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2011-12-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/3840 |
Similar Items
-
Assessment of Atorvastatin Effectiveness on Serum PSA Level in Hypercholesterolemic Males
by: Darya Khosropanah, et al.
Published: (2011-12-01) -
Antioxidant status of atorvastatin in hypercholesterolemic patients
by: Nasar Mohammad A., et al.
Published: (2009-01-01) -
Effect of cholesterol re-supplementation and atorvastatin on plaque composition in the thoracic aorta of New Zealand white rabbits
by: G. A. Bonaterra, et al.
Published: (2020-09-01) -
Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01) -
Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)